Additionally, APOε4 accelerates blood-brain barrier (BBB) disintegration and tau-associated neurodegeneration, hence APOε4 is one of the targets for AD animal and cellular models [18,19]. The gene discussed is MAPT; the disease is Alzheimer disease.